Society of Hematologic Oncology Seventh Annual Meeting (SOHO 2019)

https://www.soho2019.com/

 

Next Questions
11:45

Society of Hematologic Oncology Seventh Annual Meeting (SOHO 2019)

Next Questions in ALL: Non-Chemo Regimes, The Use of Bcl2-Bclxl Inhibitors, Importance of MRD in Complete Remission, Do We Need Allo SCT?

FEATURING Hagop Kantarjian
  • 24 views
  • October 18, 2019
10:56

Society of Hematologic Oncology Seventh Annual Meeting (SOHO 2019)

Next Questions in AML: Incorporation of New Therapies, Which Patients Should Receive Venetoclax and How, Is MRD Replacing Marrow Morphology, Origin of AML?

FEATURING Eunice Wang
  • 120 views
  • October 18, 2019
09:48

Society of Hematologic Oncology Seventh Annual Meeting (SOHO 2019)

Automated and Decentralized CAR-T Cell Manufacture: Enabling Local Manufacturing of CAR-T at the Point of Care w/in Hospitals and Medical Centers

FEATURING Boro Dropulic
  • 16 views
  • October 18, 2019
07:40

Society of Hematologic Oncology Seventh Annual Meeting (SOHO 2019)

CLL Next Questions: How To Achieve Undetectable MRD & Cure More Patients Achieving Immune Reconstruction?

FEATURING William Wierda
  • 442 views
  • October 18, 2019
  • 2
27:31

Society of Hematologic Oncology Seventh Annual Meeting (SOHO 2019)

Moving Next-Generation TKIs Into Earlier Lines of Therapy - How I Treat CML in 2019?

FEATURING Elias Jabbour
  • 112 views
  • October 18, 2019
07:09

Society of Hematologic Oncology Seventh Annual Meeting (SOHO 2019)

Next Questions in DLBCL: New Genetic Classification Based Selection of Biomarkers & Therapeutic Strategies to Overcome Immune Tolerance

FEATURING Anas Younes
  • 65 views
  • October 18, 2019
10:49

Society of Hematologic Oncology Seventh Annual Meeting (SOHO 2019)

Follicular Lymphoma - Next Steps: What is the First-Line Standard in Limited Stage and Advanced Stage (A)Symptomatic Disease?

FEATURING Robert Marcus
  • 127 views
  • October 18, 2019
10:18

Society of Hematologic Oncology Seventh Annual Meeting (SOHO 2019)

Next Qs in Peripheral T-Cell Lymphoma: the Advancement of Care, Impact of Recurring Mutations on Outcome, Transplant in First Remission for All Eligible Patients

FEATURING Owen O’Connor
  • 15 views
  • October 18, 2019
08:13

Society of Hematologic Oncology Seventh Annual Meeting (SOHO 2019)

Next Questions in Mantle Cell Lymphoma: Do We Need Chemo at All; Is There A Role for ABM, Monitoring, and Optimal Management Post BTKi

FEATURING Simon Rule
  • 116 views
  • October 18, 2019
08:39

Society of Hematologic Oncology Seventh Annual Meeting (SOHO 2019)

Next Questions in Hodgkin Lymphoma: Brentuximab Vedotin/PD-1+AVD as Frontline in Advanced Disease, as Consolidation Therapy, and Other New Drugs

FEATURING Stephen M. Ansell
  • 415 views
  • October 18, 2019
  • 3
10:18

Society of Hematologic Oncology Seventh Annual Meeting (SOHO 2019)

Next Questions in Myelodysplastic Syndromes: New Approaches for Anemia, HMAs, Targeting TP53, and Integration of alloSCT

FEATURING Guillermo Garcia-Manero
  • 20 views
  • October 18, 2019
12:02

Society of Hematologic Oncology Seventh Annual Meeting (SOHO 2019)

Next Questions in Myeloproliferative Neoplasms: What Antibody Format/MoA is Best & Can We Overcome Immunosuppressed State by the Right Choice of IO?

FEATURING Srdan Verstovsek
  • 38 views
  • October 18, 2019